Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation

Genomics Genomics
Immunology Immunology
Microbiology Microbiology
Alex K. Shalek Alex K. Shalek
Tyler Dao Tyler Dao

Xu et al.▾ Xu, J., Kong, L., Creasey, E. A., Rath, S., Deng, L., Avila-Pacheco, J., Li, C., Oliver, B. A., Dao, T. T., Shih, A. R., Daly, M. J., Shalek, A. K., Clish, C. B., Graham, D. B., Deguine, J., Xavier, R. J.

Journal of Experimental Medicine , Volume 222

September, 2025

Abstract

Genome-wide association studies (GWAS) have linked the locus encoding ankyrin repeat domain 55 (ANKRD55) with numerous autoimmune diseases; however, its biological function and role in inflammation are unclear. Here, we demonstrate that Ankrd55-deficient mice are protected from T cell–mediated colitis but are more susceptible to Citrobacter rodentium infection. Mechanistically, Ankrd55 deletion impairs CD4+ T cell proliferation and reduces effector cytokine production in T helper 17 (TH17) cells in a cell-intrinsic manner. ANKRD55 is associated with mitochondria, and its loss is associated with impaired mitochondrial respiration and activation of the LKB1 pathway. Consistently, IL-17 production can be rescued by the deletion of LKB1 in Ankrd55-deficient T cells. Altogether, our study implicates the protein ANKRD55 as a functional modulator of T cell metabolism that directly impacts TH17 responses, highlighting it as a potential target across multiple autoimmune diseases.